Economic Impact, Public Health Concerns, and Antimicrobial Resistance in Goat Mastitis

Goat farming provides important economic and livelihood support for rural communities due to its low investment requirements, adaptability to harsh environments, and contribution to milk production. However, diseases affecting dairy goats can significantly reduce productivity and threaten farm sustainability. Among these conditions, mastitis remains a major concern because it affects milk yield, milk quality, animal welfare, and overall farm profitability^1,2. 

Beyond production losses, goat mastitis also has wider implications for public health and antimicrobial resistance (AMR). Since goat milk and dairy products are consumed by humans, infections within the mammary gland may influence food safety. Inappropriate antimicrobial use during mastitis management can further contribute to resistance concerns, highlighting the important role of veterinarians in protecting animal health, food quality, and public health. 

Economic Consequences of Goat Mastitis 

Mastitis negatively affects dairy goat production by reducing milk yield, lowering milk quality, increasing treatment expenses, and contributing to premature removal of productive animals from herds. Severe cases may result in death of affected goats or transmission of infection to kids, creating additional economic challenges for farmers³. 

Clinical mastitis (CM) may have a lower occurrence compared with subclinical mastitis (SCM), but it often causes severe production losses because affected animals may experience marked reduction or complete cessation of milk production. In intensive farming systems, severe clinical cases can become an important reason for early culling³. 

Subclinical mastitis has considerable economic importance because it occurs more frequently and often remains unnoticed. It may occur 15–40 times more often than clinical mastitis, resulting in hidden losses through reduced milk production, poor milk quality, and increased risk of chronic infections³. 

Milk loss associated with subclinical infections can be significant. Reported findings indicate that subclinical mastitis caused by major pathogens may reduce milk production by approximately 0.13 kg/day during early lactation and 0.29 kg/day during late lactation⁴. 

Estimating the exact economic burden of goat mastitis remains challenging due to limited information on goat milk marketing systems, inadequate disease monitoring, and frequent underrecognition of mastitis compared with other dairy species. However, the impact on farm profitability remains an important concern requiring veterinary attention. 

Public Health Implications of Mastitic Goat Milk 

Mastitis is not only an animal health issue but also a food safety concern. Intramammary infections can alter milk composition by affecting components such as protein, fat, lactose, and immunoglobulin levels. These changes can influence the quality of dairy products including cheese, yogurt, and other milk-based products. 

Milk from mastitic goats may contain microorganisms or toxins that pose risks to consumers. Important zoonotic organisms associated with milk contamination include Staphylococcus, Streptococcus, Mycobacterium, Salmonella, Listeria, Campylobacter, E. coli, and Klebsiella species⁵. 

Fungal infections may also have public health significance. Mastitis caused by organisms such as Aspergillus, Fusarium chlamydosporum, Histoplasma, and Cryptococcus is a concern, particularly in areas where raw or inadequately processed milk is consumed^6,7. 

Another important concern is antimicrobial residues in milk. Residues from mastitis treatment can enter the food chain and may contribute to allergic reactions, gastrointestinal problems, and increased antimicrobial resistance risks among consumers¹. 

Antimicrobial Resistance: A Growing Challenge 

Antimicrobials remain important tools for treating bacterial infections; however, excessive or inappropriate use has contributed to the global challenge of antimicrobial resistance. Resistant microorganisms may no longer respond effectively to commonly used treatments, complicating disease management in both animals and humans. 

Bacteria involved in goat mastitis can develop resistance through different mechanisms, including genetic changes, reduced antimicrobial penetration, production of enzymes, toxins, and formation of biofilms. Biofilms are protective structures formed by bacterial communities that reduce susceptibility to antimicrobial agents and immune responses¹. 

Several mastitis-associated organisms have demonstrated antimicrobial resistance patterns. Staphylococcus species have shown resistance to antimicrobials including amoxicillin, oxacillin, vancomycin, tetracycline, and penicillin, while Streptococcus species have developed resistance to agents such as ampicillin, amoxicillin, and tetracycline. E. coli has also demonstrated resistance to penicillin, tetracycline, and chloramphenicol¹. 

Role of Veterinarians in One Health-Based Mastitis Management¹ 

The connection between animal health, human health, and environmental health highlights the importance of a One Health approach in mastitis control. Farmers and veterinarians share responsibility for maintaining animal welfare, milk safety, and responsible antimicrobial practices. 

Veterinary guidance is essential for promoting appropriate diagnosis, targeted antimicrobial selection, treatment monitoring, and preventive herd management. Judicious antimicrobial use not only improves mastitis management but also helps protect the effectiveness of these medicines for future use. 

Practical Clinical Insights 

• Consider mastitis as both a production disease and a public health concern. 

• Encourage early detection to reduce chronic infections and milk losses. 

• Avoid unnecessary antimicrobial use without appropriate clinical assessment. 

• Promote hygienic milking practices and farmer awareness to improve milk safety. 

• Integrate animal, human, and environmental health considerations into mastitis control programs. 

Conclusion 

Goat mastitis creates challenges that extend beyond reduced milk production. Economic losses, food safety concerns, and antimicrobial resistance make it a significant issue requiring coordinated veterinary intervention. Through accurate diagnosis, responsible treatment decisions, preventive management, and farmer education, veterinarians can play a central role in improving dairy goat health while supporting safer and more sustainable milk production systems. 

References 

1. Tibebu A, Teshome Y, Tamrat H, Bahiru A. Mastitis in goat: A review of etiology, epidemiology, economic impact, and public health concerns. One Health. 2025 Dec 1;21:101131. https://www.sciencedirect.com/science/article/pii/S2352771425001673 

2. Yuan YG, Peng QL, Gurunathan S. Effects of silver nanoparticles on multiple drug-resistant strains of Staphylococcus aureus and Pseudomonas aeruginosa from mastitis-infected goats: an alternative approach for antimicrobial therapy. International journal of molecular sciences. 2017 Mar 6;18(3):569. https://www.mdpi.com/1422-0067/18/3/569 

3. Moni MI, Samad MA. Prevalence and risk factors of subclinical mastitis in lactating black Bengal goats detected by using indirect and direct methods of SCC in Bangladesh. J. Veterin. Med. One Health Res. 2020;2(1):115-38. https://www.academia.edu/download/110306304/jvmohr.2020.21.pdf 

4. Koop G, Van Werven T, Schuiling HJ, Nielen M. The effect of subclinical mastitis on milk yield in dairy goats. Journal of dairy science. 2010 Dec 1;93(12):5809-17. https://www.sciencedirect.com/science/article/pii/S0022030210006314 

5. Gallo M, Ferrara L, Calogero A, Montesano D, Naviglio D. Relationships between food and diseases: What to know to ensure food safety. Food Research International. 2020 Nov 1;137:109414. https://www.farmacia.ufmg.br/wp-content/uploads/2021/04/Gallo-et-al.-2020.pdf 

6. Hayle WA, Ahmed R, Uddin ME. Prevalence of subclinical mastitis among small ruminants and isolation of some etiological bacterial pathogens in Jimma Town, Ethiopia. European Journal of Medical and Health Sciences. 2020 Nov 19;2(6):107-24. https://www.universepg.com/ejmhs/prevalence-of-subclinical-mastitis-among-small-ruminants-and-isolation-of-some-etiological-bacterial-pathogens-in-jimma-town-ethiopia 

7. Adelowo MT, Adeyeye AA, Aliyu RM, Sanusi M. Survey for Fungal Agents Associated with Clinical Mastitis in Red Sokoto Does at the Sokoto Livestock Market, Nigeria and their Antifungal Susceptibility Pattern. Nigerian Journal of Microbiology. 2022 Dec;6(2):6284-91. https://www.researchgate.net/profile/Adewale-Adeyeye/publication/366291102